SCHEMBL31723153

SCHEMBL31723153

O=C(O)c1c(-c2cc(F)cc(F)c2)oc2ccccc2c1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.56
MEN1 O00255 6/20 0.56
KDM4E B2RXH2 6/20 0.56
MAPT P10636 4/20 0.56
ALDH1A1 P00352 4/20 0.56
HPGD P15428 3/20 0.56
HTT P42858 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
CYP3A4 P08684 4/20 0.49
ALOX15 P16050 3/20 0.49
MAPK1 P28482 3/20 0.49
LMNA P02545 2/20 0.49
TP53 P04637 2/20 0.49
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
ABCB1 P08183 1/20 0.49
CALM1 P0DP23 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20919116 1.00 KMT2A (0.56) KMT2AMEN1KDM4EMAPTALDH1A1
SCHEMBL31723120 0.89 KMT2A (0.57) KMT2AMEN1KDM4EMAPTALDH1A1
SCHEMBL20918216 0.89 KMT2A (0.57) KMT2AMEN1KDM4EMAPTALDH1A1
SCHEMBL6527669 0.85 ALDH1A1 (0.69) KMT2AMEN1KDM4EMAPTALDH1A1
SCHEMBL9528127 0.83 MEN1 (0.57) KMT2AMEN1KDM4EMAPTALDH1A1
SCHEMBL20919218 0.83 KMT2A (0.53) KMT2AMEN1KDM4EMAPTALDH1A1
SCHEMBL20919240 0.83 MAPT (0.60) KMT2AMEN1KDM4EMAPTALDH1A1
SCHEMBL31723116 0.83 KMT2A (0.53) KMT2AMEN1KDM4EMAPTALDH1A1
SCHEMBL20918210 0.83 MAPT (0.74) KMT2AMEN1KDM4EMAPTALDH1A1
SCHEMBL31723169 0.83 MAPT (0.74) KMT2AMEN1KDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3699174-B1 COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED DISEASES, CONTAINING DERIVATIVE AS ACTIVE INGREDIENT, AND METHOD FOR INHIBITING TNF ACTIVITY BY USING SAME ILAB (KR) 2025-11-12 EP claimed